ABSTRACT
Acinetobacter baumannii has emerged in the last decade as an important nosocomial pathogen. To identify genes involved in the course of a pneumonia infection, gene expression profiles were obtained from A. baumannii ATCC 17978 grown in mouse infected lungs and in culture medium. Gene expression analysis allowed us to determine a gene, the A1S_0242 gene (feoA), over-expressed during the pneumonia infection. In the present work, we evaluate the role of this gene, involved in iron uptake. The inactivation of the A1S_0242 gene resulted in an increase susceptibility to oxidative stress and a decrease in biofilm formation, in adherence to A549 cells and in fitness. In addition, infection of G. mellonella and pneumonia in mice showed that the virulence of the Δ0242 mutant was significantly attenuated. Data presented in this work indicated that the A1S_0242 gene from A. baumannii ATCC 17978 strain plays a role in fitness, adhesion, biofilm formation, growth, and, definitively, in virulence. Taken together, these observations show the implication of the feoA gene plays in the pathogenesis of A. baumannii and highlight its value as a potential therapeutic target.
KEYWORDS: Acinetobacter baumannii, iron uptake, virulence, animal infection models
Introduction
Acinetobacter baumannii is a Gram negative, non-fermentative, and non-flagellated bacillus. Although it is a normal inhabitant of human skin, intestinal tract and respiratory system, it is currently considered one of the most dangerous opportunistic pathogens. Recently, the World Health Organization included A. baumannii in a list of the most important antibiotic resistant pathogens [1]. This bacterium exhibits an excellent ability to develop antibiotic resistance which often results in strains resistant to several antimicrobial families [2,3]. Carbapenems are broadly used to treat A. baumannii multiresistant strains; however, resistance to these antimicrobials increased dangerously in the last decade [4]. Similarly, an increment of resistance rates is emerging in the case of last resort antimicrobials such as colistin [5] or tigecycline [6]. Resistance to these antimicrobials has also appeared which lead us to the urgent need to design and evaluate new antimicrobial therapies. In the last decades, the number of hospital outbreaks caused by A. baumannii has increased noticeably, partly due to its multidrug resistance profile [2,7–10]. Although the clinical importance of A. baumannii infections has increased, the pathogenicity of this microorganism is sparsely understood. Clinical A. baumannii strains exhibit remarkably variations in virulence-associated phenotypes such as motility, adherence, biofilm formation, invasion, iron uptake or cell capsule development among others [11,12]. Some studies have shown that Acinetobacter species may reach the human skin and mucosal membranes and then colonize and persist on the host several weeks [13]. Bacterial adherence constitutes an essential step in the colonization process. The ability of the AbH12O-A2 strain, which caused the largest outbreak of A. baumannii known worldwide [14–19], to adhere to human cells was one of the main factors involved in its persistence [14]. After adhesion, bacteria may form biofilms that are involved in the persistence of this pathogen in the hospital environment. Some components, such as the staphylococcal biofilm-associated protein (Bap), the CsuA/BABCDE usher-chaperone system or the poly-beta-1–6-N-acetylglucosamine have been described as involved in the A. baumannii biofilm formation and adherence phenotypes [20–24]. The outer membrane protein OmpA plays a role in biofilm formation on abiotic surfaces and has been shown to promote the adherence to eukaryotic host and invasion [25].
Iron is essential for growth in most bacteria due to its redox activity and its role in many vital metabolic reactions, being a cofactor for many bacterial enzymes. Therefore, iron is necessary for bacteria to infect and multiply in tissues and body fluids of the host, playing a relevant role in pathogenesis [26]. Under in vivo conditions, iron is not readily available due to cells uptake or sequestration by proteins such as transferrin or lactoferrin, which are components of the innate immunity system that provide defense against pathogens [27,28]. Bacteria encode multiple iron uptake pathways, which provide specificities and affinities for various forms of environmental or host iron. Under iron-limited conditions many invading bacteria respond by producing specific iron chelators, such as siderophores, that remove the iron from the host sources [29-31]. In addition, many bacteria, such as Escherichia coli, Shigella flexneri, Helicobacter pylori, Campylobacter jejuni or Legionella pneumophila, take up soluble ferrous iron via the Feo system [32–40], which is proposed to be the major ferrous iron transport system known in prokaryotes [41]. The Feo system was first identified in E. coli [42,43] and it is encoded by the feoABC operon. FeoB, a bacterial ferrous iron transporter, is composed of a hydrophilic cytoplasmic domain and an integral membrane domain [44,45]. The C-terminal membrane domain of FeoB is responsible for the formation of a pore in the membrane and the N-terminal contains a GTP-binding domain that regulates the transport activity. The roles of feoA and feoC remain unknown although feoC is predicted to encode for a transcriptional repressor of feoAB [32,43,45]. In pathogenic bacteria such as E. coli, H. pylori or L. pneumophila, mutations in the feoB gene have been shown to cause deficiency in ferrous iron uptake and virulence [26,33,37–39], including assays emulating conditions encountered during infection of a mammalian host [46]. High-throughput sequencing technologies demonstrated the presence of the Feo system in 50 clinical strains of A. baumannii [47].
In the present work, we identified a gene over-expressed during the course of the lung infection of A. baumannii in mice, the A1S_0242 gene (feoA). We evaluated the role of this gene in fitness, biofilm production, attachment to biotic surfaces, resistance to oxidative stress, and, finally, in the pathogenesis of A. baumannii using Galleria mellonella and murine pneumonia models.
Results
Genetic context of the feoA gene
Transcriptomic analysis revealed a collection of genes differentially expressed in the A. baumannii lung infection model. Raw data have been deposited in the GEO database under the accession code GSE100552. Between them, the A1S_0242 (feoA) gene was over-expressed in bacteria over the course of the lung infection compared to bacteria grown in LB media, as shown by Illumina (2.67-fold more +/− 0.75) and qRT-PCR (6.34-fold more +/− 2.03) analysis.
The genetic context of this gene was studied. The feoA gene, previously annotated in the ATCC 17978 genome (CP018664.1) as a putative ferrous iron transporter protein A containing a feoA domain, was found as part of a single operon comprising genes A1S_0242, A1S_0243 and A1S_0244, as assessed by RNA reverse transcription (Figure 1). The A1S_0243 gene was annotated in the ATCC 17978 genome (CP018664.1) as a ferrous transport protein B harboring a feoB domain. The A1S_0244 gene was found as a hypothetical protein, with no conserved domains. Real time RT-PCR assays confirmed that both A1S_0243 and A1S_0244 surrounding genes were over-expressed during the lung infection (1.95-fold more +/− 0.36 and 2.78-fold more +/− 0.96, respectively) compared with genes from bacteria grown in LB-flasks.
Moreover, two homologues to the A1S_0242 gene were found in the A. baumannii ATCC 17978 genome (CP018664.1). These genes were A1S_3850 and A1S_0652 that showed 53% and 54% of identity with the feoA gene, respectively. The A1S_3850 gene, previously annotated in the ATCC 17978 genome as a hypothetical protein, is part of a single operon comprising genes A1S_2929, A1S_3850 and A1S_2930 (data not shown). The A1S_2929 and the A1S_2930 genes were annotated as a putative cation efflux system protein and a putative ferrous iron transport protein B containing a feoB domain, respectively. The A1S_0652 gene was annotated as a putative ferrous iron transport protein A containing a feoA domain followed by the A1S_0653 gene encoding a putative ferrous iron transport protein B. Deeper bioinformatic analysis revealed that the A1S_0652 gene was located in the plasmid pAB3 (GenBank accession number CP012005) of the A. baumannii ATCC 17978-mff strain (CP012004.1) while the A1S_3850 was found in the chromosome.
All the publicly available complete genomes of A. baumannii were analyzed in order to find the A1S_0242 and the A1S_3850 genes. The A1S_0242 gene was found in the 100% of the 76 A. baumannii complete genomes analyzed, while the A1S_3850 gene was located in the 14.5% of them. Similarly, in species such as A. pittii, A. nosocomialis, A. soli or A. calcoaceticus, the A1S_3850 gene was occasionally found while the A1S_0242 gene was present in all the analyzed genomes.
The discovery of these two A1S_0242 homologues induced us to investigate possible interactions between those three genes, being the A1S_0242 gene the main objective of our work. Gene knockout mutants of the ATCC 17978 strain lacking the A1S_0242 and A1S_3850 genes were constructed in order to analyze their interaction. Therefore, the isogenic mutant derivatives Δ0242 and Δ3850 strains as well as the double mutant Δ0242/Δ3850 strain were obtained. Due to the plasmid location of the A1S_0652 gene, it was not possible to perform a knockout mutant lacking this gene.
The complementation of the A1S_0242 gene with the parental allele (Δ0242 complemented) was performed through the over-expression of the gene cloned into the pWH1266-Km vector. Data from qRT-PCR analysis revealed that indeed the A1S_0242 was highly over-expressed under the control of the tetracycline promoter compared to its expression in the wild type gene (Table S1). As expected, the Δ0242 strain, as well as the Δ0242 strain harboring the empty pWH1266-Km vector (Δ0242 + pWH1266-Km), revealed no expression of the A1S_0242 gene. Table S1 also shows that there is no expression of the A1S_3850 gene in the Δ3850 strain and the over-expression of the A1S_3850 gene from the plasmid was confirmed.
Also qRT-PCR analyses were performed in order to investigate the effects of the lack of the A1S_0242 gene on the expression of its homologue genes. Data revealed that when the A1S_0242 gene was absent, the A1S_3850 and the A1S_0652 genes maintained their expression levels (Table 1). Also, the deletion of the A1S_3850 did not vary the expression of the A1S_0242 gene whereas the expression of the A1S_0652 gene increased. In addition, the deletion of both A1S_0242 and A1S_3850 genes revealed a minimal increase in the A1S_0652 expression level, due to the effect of the A1S_3850 gene.
Table 1.
ATCC 17978 | Δ0242* | Δ3850* | Δ0242/Δ3850* | |
---|---|---|---|---|
A1S_0242 | 1 | 0 | 1.02 +/− 0.32 | 0 |
A1S_0652 | 1 | 0.97 +/− 0.21 | 2.73 +/− 1.09 | 1.11 +/− 0.48 |
A1S_3850 | 1 | 0.97 +/− 0.04 | 0 | 0 |
Data were obtained as a fold-change relative to the ATCC 17978 sample (value 1), using the rpoB gene as housekeeping for normalization.
Next, the abilities of the Δ0242 strain and its isogenic derivative mutants were tested under in vitro and in vivo conditions to confirm the role of this gene in fitness and virulence. The A1S_3850 mutants were also included in some assays in order to discard its relevance in the pathogenesis of the ATCC 17978 strain.
Effects of the feoA gene deletion and vector loading on fitness
To determine whether the deletion of genes A1S_0242 and A1S_Δ3850 affect the bacterial growth rate, growth curve rates were measured in iron-sufficient and iron-restricted media. Determination of the growth rate constant (μ) gives a measure of fitness or replication ability [48]. The growth rates of the Δ0242 mutant did not show significant differences compared to the wild type strain in presence of iron (Figure 2). However, when the metal chelator 2,2´-bipyridil (BIP) was added to the medium, the mean generation of the Δ0242 mutant was higher (65 min, µ = 0.0105 +/− 0.0003) with respect to the ATCC 17978 strain (45 min, μ = 0.015 +/− 0.0012), showing significant differences in fitness (p > 0.05). In contrast, the deletion of A1S_Δ3850 did not show inhibition of growth compared with the ATCC 17978 parental strain. In agreement with these results, the double mutant Δ0242/Δ3850 showed a growth rate similar to the single mutant Δ0242 in BIP presence (Figure 2).
Studies of bacterial growth performed with the ATCC 17978 derivative strains carrying the pWH1266-Km vector showed that this plasmid load represents a very relevant biological cost, as shown in Figure S1. These means that all the strains carrying the pWH1266-Km vector showed a significantly lower fitness than the wild type strain. For this reason, complemented strains were not included in assays where the growth rate was limiting.
The feoA gene deletion reduces biofilm formation and attachment to eukaryotic cells abilities
The biofilm formation ability was evaluated and the Δ0242 mutant derivative strain showed a significant decrease (ca. 2,15-fold less, p = 0.0034) with respect to the ATCC 17978 parental strain (Figure 3). Complementation of the strain with the parental allele partially restored the biofilm formation phenotype. Deletion of the A1S_3850 revealed no significant differences in biofilm formation with respect to the wild type strain. Biofilm formation was similar for the single Δ0242 and the double mutant Δ0242/Δ3850 strains.
As shown in Figure 4, the inactivation of the A1S_0242 gene led to a reduction in the ability of the A. baumannii strain ATCC 17978 to adhere to human alveolar epithelial cells A549 (ca. 4-fold, p value < 0.0001). In this case, the fitness of the strains was a limiting factor as can be seen in Figure S2, the wild type strain harboring the plasmid (ATCC 17978 + pWH1266-Km) showed an important decrease in biofilm formation ability, compared with the wild type strain (ATCC 17978). The complemented strain (Δ0242 complemented) partially restored the wild type phenotype loading plasmid (ATCC 17978 + pWH1266-Km), as reflected in Figure S2. As shown in Figure S1, all strains harboring the pWH1266-Km vector resulted in an increase in the lag time and in a lower optical density at the end of growth curve analysis, which indicates a fitness decrease caused by the plasmid metabolic load. Besides, the Δ3850 strain showed no significant differences with respect to the wild type and the double mutant strain showed similar attachment abilities as the Δ0242 strain (Figure 4). No invasiveness was detected at 24 h in all cases (data not shown).
Effects of the feoA gene inactivation on susceptibility to oxidative stress
When strains were subjected to reaction oxygen species (ROS) by the addition of paraquat in the presence of 100 µM of the iron chelator 2,2´-bypiridyl (BIP), the Δ0242 mutant strain showed a MIC to paraquat of 8 mg/L, while the wild type strain ATCC 17978 showed a value of 32 mg/L, which indicates a significant increase in susceptibility to oxidative stress of the mutant strain with respect to the wild type strain (Table 3). No differences were found in the susceptibility to paraquat between the Δ0242 mutant and the Δ0242/Δ3850 double mutant (MIC of 8 mg/L). In concordance, the Δ3850 mutant neither showed significant differences with respect to the wild type strain (MIC of 32 mg/L). A slightly higher susceptibility to paraquat in the Δ0242 mutant was also observed in the medium without limitation of metal availability. Besides, when the strains carried the plasmid pHW1266-Km, the susceptibility to paraquat increased in all cases, due to the fitness loss as explained above (Figure S1). In Table 3 it can be observed that, even taking into account this global increased of susceptibility to paraquat in strains carrying the plasmid, the phenotype of higher susceptibility to oxidative stress in the presence of BIP of the Δ0242 mutant strain carrying the plasmid (Δ0242+pWH1266-Km, MIC of 1 mg/L) was restored in the complemented strain, this showing the same MIC to paraquat as the wild type strain carrying the pWH1266-Km vector (MIC of 4 mg/L).
Table 3.
MICs to paraquat (mg/L) | ||
---|---|---|
|
MH broth |
MH broth + 100 µM BIP |
ATCC 17978 | 64 | 32 |
Δ0242 | 32 | 8 |
Δ3850 | 64 | 32 |
Δ0242/Δ3850 | 32 | 8 |
MICs to paraquat (mg/L) with strains carrying the pWH1266-Km vector | ||
ATCC 17978 + pWH1266-Km | 8 | 4 |
Δ0242 + pWH1266-Km | 4 | 1 |
Δ0242 complemented | 4 | 4 |
The feoA gene is involved in virulence
In order to explore the role of the feoA gene during the course of the in vivo infection, experimental animal models were performed in G. mellonella and mice.
The A. baumannii ATCC 17978 and the Δ0242, Δ3850 and Δ0242/Δ3850 derivative mutant strains were tested in the G. mellonella infection model. The survival assays (Figure 5) showed that the Δ0242 and Δ0242/Δ3850 mutant strains were significantly affected in their ability to infect and kill the caterpillars compared with the wild type strain (p < 0.05).
These results were in agreement with the mortality rates of G. mellonella infected with different inocula of the A. baumannii strains (Table 4). Briefly, lethal doses (LD) of the ATCC 17978 strain were similar to those showed by the mutant Δ3850. Besides, the lethal doses of the mutant Δ0242 were similar to those found in the Δ0242/Δ3850 mutant strain. The inactivation of the gene A1S_3850 did not affected the virulence ability of the ATCC 17978 strain using this G. mellonella infection model. The LD50 of the ATCC 17978 strain and the Δ3850 mutant was approximately 5-fold lower than that of the Δ0242 and Δ0242/Δ3850 mutant strains at 24 h, and 3.5-fold lower at 144 h. The LD100 of the ATCC 17978 strain and the Δ3850 mutant was approximately 4-fold lower than that of the Δ0242 and Δ0242/Δ3850 mutant strains at 24 h, and 3-fold lower at 144 h.
Table 4.
Bacterial inoculum (CFUs/larva) |
||||||||
---|---|---|---|---|---|---|---|---|
8*105 | 2*105 | 8*104 | 2.6*104 | 8*103 | 2.6*103 | |||
Strains | Mortality of larvae (%)at 24 h | LD50 24 h | LD100 24 h | |||||
ATCC 17978 | 100 | 100 | 85.7 | 57.1 | 42.8 | 0 | 1.9*104 | 17*104 |
Δ0242 | 100 | 71.4 | 57.1 | 0 | 0 | 0 | 10.5*104 | 63*104 |
Δ3850 | 100 | 100 | 100 | 42.8 | 28.5 | 0 | 1.95*104 | 11.7*104 |
Δ0242/Δ3850 | 100 | 85.7 | 57.1 | 0 | 0 | 0 | 9.3*104 | 53.2*104 |
Strains | Mortality of larvae (%) at 144 h | LD50 144 h | LD100 144 h | |||||
ATCC 17978 | 100 | 100 | 100 | 85.7 | 42.8 | 0 | 1*104 | 6*104 |
Δ0242 | 100 | 100 | 85.7 | 14.2 | 0 | 0 | 4.35*104 | 18.1*104 |
Δ3850 | 100 | 100 | 100 | 100 | 28.5 | 0 | 1.15*104 | 3.05*104 |
Δ0242/Δ3850 | 100 | 100 | 85.7 | 42.8 | 0 | 0 | 3.4*104 | 16.4*104 |
The virulence of the ATCC 17978 and Δ0242 strains was also assessed using a murine pneumonia model by measuring survival time of infected mice. Two groups of 10 mice were intratracheally infected with 5.5 × 107 CFUs/mouse, which means a LD90 of the wild type strain. However, the same dose of the Δ0242 mutant derivative strain produced only 30% of mortality (Figure 6A). Thus, a significant decrease in virulence using a mouse pneumonia model was observed when the gene A1S_0242 was deleted (p < 0.01).
A second model was also performed using an experimental pneumonia model in mice in order to determine the bacterial load in lungs and the frequency of sterile blood cultures (Table 5 and Figure 6B). Data revealed that, in groups inoculated with the ATCC 17978 strain, the bacterial load was approximately 1 log higher than in mice inoculated with the Δ0242 mutant strain (p < 0.01). Besides, the frequency of sterile blood cultures increased up to 75% in the group inoculated with the Δ0242 mutant strain compared with the mice inoculated with the ATCC 17978 strain (8.4%), (p < 0.01). Similarly, the survival time was significantly higher in the group of mice inoculated with the Δ0242 mutant strain than in the mice harboring the wild type strain (p < 0.01).
Table 5.
Treatment group (n) | Bacterial load in lung (mean log10CFU/g of lung +/− SD) | % Sterile blood cultures | Mean of survival time (h) of mice |
---|---|---|---|
ATCC 17978 (12) | 11.04 (+/− 0.35) | 8.4% | 43.4 |
Δ0242 (12) | 10.04 (+/− 0.29) | 75% | 64.1a |
: Two mice survived at 72 h.
Discussion
The success of lung infection partly depends on the ability of bacteria to acquire iron, a cofactor needed for many enzymatic reactions. Iron is essential for vital functions of bacteria and its presence in the host environment is restricted. This iron restriction constitutes an immune defense mechanism. A. baumannii is able to grow under iron-limiting conditions such as those occurred during human infection, however there is scarce information about the iron uptake of this microorganism during the course of the infection. Different studies showed that A. baumannii produces siderophores [49] such as the iron chelating agent acinetobactin [18,31,47], the fimsbactin A-F [29] or the baumanoferrin A and B [30] which are required for virulence. In addition, some outer membrane proteins such as OprD and OmpW have been related to iron uptake in A. baumannii [50,51]. Recently, a study concerning the gene expression profile of A. baumannii revealed that most of the genes hyper-expressed during bacteremia were those involved in iron transport and uptake [52].
At neutral pH and aerobic conditions, the ferric iron Fe3+ is insoluble. At this point, bacteria depend on siderophores for the iron uptake, such as acinetobactin, pyoverdin or enterobactin, previously described in A. baumannii, P. aeruginosa and E. coli, respectively [53,54], as well as additional molecules with Fe-chelating ability, such as citrate in P. aeruginosa [55]. In contrast, in anaerobic conditions, ferrous iron Fe2+ is abundant and is captured through uptake systems [56], such as the Feo system. However, a relevant link exists between the Feo system and the citrate-mediated Fe3+ acquisition of P. aeruginosa. The ferric iron Fe3+ chelated by citrate must be reduced to Fe2+ prior to its transport into the cytosol by the membrane transporter FeoB. A ferric citrate-specific cytoplasmic membrane transport component is absent in P. aeruginosa [57,58]. Similar cooperation between the FeoB transporter and the citrate-promoted Fe acquisition has been suggested in other species, such as H. pylori [37] and Leptospira biflexa [59]. Genes encoding for the baumanoferrin biosynthetic gene cluster found in A. baumannii [30] showed to be homologous to components of the acinetoferrin system, a citrate-based siderophore described in A. haemolyticus [60]. However, similar relationships between these siderophores and the Feo system are yet unknown.
Transcriptome analysis of A. baumannii ATCC 17978 strain, using RNA isolated from BAL of the infected lungs as starting material, revealed that the A1S_0242 gene (a ferrous iron transporter protein A) was over-expressed during the course of the pneumonia infection. Further analysis of the genome revealed the presence of other two genes (A1S_3850 and A1S_0652) homologues to A1S_0242, both harboring a feoA domain. This motivated us to study the genetic context of those genes. Informatic analyses revealed the presence of the A1S_0242 gene in all the complete A. baumannii genomes while the A1S_3850 and the A1S_0652 genes were rarely found.
The Feo systems found in A. baumannii ATCC 17978 contain in all cases genes similar to the previously described feoA and feoB genes but lacks the feoC gene found in other species. More functional studies related to the A1S_0244 could explain if this gene could act as a feoAB repressor in A. baumannii. The presence of these three genes containing a feoA domain in the strain ATCC 17978 triggered us to study the function of the A1S_0242 (feoA) and its interaction with the other two homologue genes (A1S_3850 y A1S_0652). Real time procedures revealed that the lack of A1S_0242 does not vary A1S_0652 and A1S_3850 expression while deletion of A1S_3850 increased the A1S_0652 expression.
In a previous work [61], transcriptional profiles indicated that the A1S_0242 and the A1S_3850 genes expression remained unaltered in biofilm-associated cells when compared to the planktonic cells, while the A1S_0652 gene increased. However, when the transcriptional profile of A. baumannii was determined during bacteremia [52], it was recovered that the expression of A1S_0650 and A1S_3850 genes remained unaltered whereas the expression of the A1S_0242 gene increased. Moreover, Eijkelkamp et al. [62] studied the transcriptional profiles of the genes of A. baumannii under iron limiting conditions. In this case, it was found that the A1S_0242 and A1S_0652 genes were up-regulated under iron limiting conditions while the A1S_3850 gene did not showed any different expression profile.
In this study we report many evidences of the implication of the A1S_0242 gene (feoA) in fitness and virulence of A. baumannii ATCC 17978. The importance of the feoA gene was first evidenced in fitness. The Δ0242 mutant showed a lower growth rate than the wild-type strain in iron-limited conditions. In contrast the mutants Δ3850 and Δ0242/Δ3850 did not decreased in growth rates compared with the parental and Δ0242 strains, respectively, thus minimizing the relevance of the A1S_3850 gene present in the ATCC 17978 strain.
Significant differences were also found in biofilm production or cellular attachment. The deletion of feoA demonstrated that this gene was involved is those mechanisms used by A. baumannii to colonize and infect the host organs while deletion of the homologue gene A1S_3850 did not show any changes. In agreement with previous results, the mutant Δ0242 showed a higher susceptibility to oxidative stress than the wild-type strain. Superoxide dismutase plays a key role in metabolizing O2−, avoiding reactions that can cause damage and the formation of reactive oxygen species. This enzyme frequently uses Fe as metal cofactor to catalyze the detoxification of superoxide [63]. Therefore, the Δ0242 mutant strain was more susceptible to the oxidative stress induced by paraquat probably due to decreased superoxide dismutase activity. The Δ3850 and the double mutant Δ0242/Δ3850 did not showed any effect on biofilm production, cellular attachment or oxidative stress, which once more highlights the important role of the A1S_0242 gene in pathogenesis and indicates the irrelevant role of the A1S_3850 gene in these processes.
Fitness is usually defined as the capacity for survival and reproduction in a particular environment [64], and virulence is defined as the degree of pathogenicity (ability of an agent to cause disease). Most pathogens use of a combination of two properties to cause disease: (i) toxicity, the degree to which a substance causes harm, and (ii) invasiveness, the ability to penetrate into the host and spread [48,65]. In the present study we have proved that fitness is reduced when the feoA gene (A1S_0242) is inactivated under iron-limited conditions. Additionally, virulence decreased as judged by the reduced ability of the mutant Δ0242 strain to attach to alveolar cells and the increased susceptibility to oxidative stress, which is one of the main antibacterial mechanisms during phagocytosis [66], being all these processes implicated in the pathogenicity of A. baumannii. Data indicated that the increase of survival and lethal doses obtained in the in vivo models with the Δ0242 mutant strain is probably due to a double effect or synergy between the fitness lost and the decrease of virulence, caused by a reduced ability to arrest iron from the environment.
Moreover, complementation experiments were performed in order to better demonstrate the role of feoA in virulence. Since the load of the pWH1266-Km vector decreases fitness (see Figure S1) not all assays could be performed with the complemented mutants. Accordingly, those assays in which fitness does not play a relevant role, such as biofilm production, were performed including the complemented strains. These assays clearly demonstrated that the complementation is possible and indeed restored the original phenotype. However, those assays where fitness is a limiting factor, such as the in vivo assays in animal models, were carried out without the complemented strains.
In a recent screening of genes involved in bacterial survival of A. baumannii using a mouse model of bloodstream infection, from a transposon mutant library comprising more than 100,000 mutants, 89 were selected for further studies [46]. Between them, two genes belonged to iron uptake systems, the fepA and the feoB genes, supporting the role of these systems in the A. baumannii pathogenesis [46]. However, no in vivo assays were performed on the study to confirm the results. In the present study, the implication of FeoA in the pathogenesis of A. baumannii was also evidenced using experimental in vivo infections that imply the host response. In the first model, previously validated to study A. baumannii infections in iron-defective conditions [18,67], caterpillars of G. mellonella were infected with the wild-type and mutant strains. Data indicated an impaired in virulence showing a lower capacity to persists and kill the caterpillars in the case of the Δ0242 strain but not in the case of the Δ3850 strain, which shows again the lack of implication of the A1S_3850 in pathogenesis. Similarly, in the pneumonia models of infection in mice, the mutant Δ2042 strain with reduced iron transport functions was less virulent than the wild-type strain. Both assays with invertebrate and vertebrate hosts reflected similar effects. Taken together these observations indicate that the feoA gene of A. baumannii is essential for the full virulence of this microorganism. However, virulence of A. baumannii, using the animal models here presented, was not entirely inhibited, suggesting that other iron transport systems previously described such as fepA, acinetobactin, baumanoferrin or fimsbactin [29,30,46,47] are present in the ATCC 17978 strain and should be active when the Feo system is abolished.
In summary, data indicated that the A1S_0242 gene (feoA) from A. baumannii ATCC 17978 strain, which is involved in iron uptake and that was found as over-expressed during the course of a pneumonia infection, plays a role in adhesion, biofilm formation and resistance to oxidative stress. Definitively, in the present study we demonstrated that the FeoA protein is needed for the full virulence phenotype of the strain ATCC 17978 of A. baumannii and that the FeoA-mediated acquisition of iron is essential for the A. baumannii pathogenesis.
Material and methods
Bacterial strains
A. baumannii ATCC 17978 and its derivative strains and E. coli listed in Table 2 were routinely grown or maintained in Luria-Bertani (LB) or Mueller-Hinton (MH) media with 20% agar added for plates for general purposes. All strains were grown at 37 °C and stored at -80 °C in LB broth containing 10% glycerol. When appropriate, cultures were supplemented with kanamycin (Km) at a final concentration of 50 mg/L (Sigma-Aldrich, #K1377).
Table 2.
Strain or plasmid | Relevant characteristics | Sources or references |
---|---|---|
STRAINS | ||
A.baumannii | ||
ATCC 17978 | Clinical isolate | ATCC |
Δ0242 | A1S_0242 gene deletion mutant obtained from the ATCC 17978 strain | This study |
ATCC 17978 + pWH1266-Km | ATCC 17978 harboring the empty pWH1266-Km plasmid; KmR, TetR | This study |
Δ0242 + pWH1266-Km | Δ0242 harboring the empty pWH1266-Km plasmid; KmR, TetR | This study |
Δ0242 complemented | Δ0242 harboring the pWH1266-Km-0242 plasmid; KmR | This study |
Δ3850 | A1S_3850 gene deletion mutant obtained from the ATCC 17978 strain | This study |
Δ3850 + pWH1266-Km | Δ3850 harboring the empty pWH1266-Km plasmid; KmR, TetR | This study |
Δ3850 complemented | Δ3850 harboring the pWH1266-Km-3850 plasmid; KmR | This study |
Δ0242/Δ3850 | A1S_0242 and A1S_3850 genes deletion double mutant obtained from the ATCC 17978 strain | This study |
E. coli | ||
TG1 | Used for DNA recombinant methods | Lucigen |
PLASMIDS | ||
pWH1266-Km | A. baumannii shuttle vector; KmR, TetR | Álvarez-Fraga et al. 2016 [68] |
pWH1266-Km-0242 | pWH1266-Km harboring the A1S_0242 gene; KmR | This study |
pWH1266-Km-3850 | pWH1266-Km harboring the A1S_3850 gene; KmR | This study |
pMo130 | Suicide vector for the construction of A. baumannii isogenic derivative; KmR, SacB, XylE | Hamad et al. 2009 [69] |
KmR: kanamycin resistance. TetR: tetracycline resistance.
Bacterial RNA extraction from murine pneumonia infection
An experimental pneumonia model was used to describe the transcriptome of the ATCC 17978 strain during the course of the infection. BALB/c 9- to 11-week old male mice weighing 25 to 30 g were intratracheally inoculated with approximately 5.5 × 107 CFUs/mouse of exponentially grown cells of the ATCC 17978 strain into mice. The number of bacteria present in the inoculum was checked by plate counting in LB agar plates. Briefly, mice anesthetized with an oral suspension of sevoflurane (Zoetis, #NADA 141–103) were suspended by their incisors on a board in a semi-vertical position. The efficacy of the intratracheal inoculation was confirmed by using an endoscope on the oral cavity. The trachea was accessed using a blunt-tipped needle for the inoculation of a 40-μL bacterial suspension made in sterile saline solution and 10% porcine mucin (wt/vol) (Sigma) mixed at a 1:1 ratio. A solution of ketamine (500 µg/mouse) (Pfizer, #47639/24/15) and medetomidine (15 µg/mouse) (Domtor, #933ESP) was immediately intraperitoneally injected after inoculation in order to keep the mice at least 20 min in a 30° inclined position. Dead mice in the first 4 h after inoculation were not included in the final analyses. Mice were euthanized with an overdose of thiopental sodium (Sandoz, NDC0781–6160-43) 20 h after inoculation. Then, a bronchoalveolar lavage (BAL) was performed to obtained bacteria suitable for RNA extraction (in vivo samples). All mice were maintained in the specific pathogen-free facility at the Technology Training Center of the Hospital of A Coruña (CHUAC, Spain). All experiments were done with the approval of and in accordance with regulatory guidelines and standards set by the Animal Ethics Committee (CHUAC, Spain, project code P82), in accordance with the Helsinki Declaration of 1975. RNA extracted from bacteria grown in LB-flasks (OD600 = 1.0) at 37°C and 180 rpm was used as experimental control (in vitro samples). Total RNA was immediately extracted from both samples using the RNeasy Mini Kit (Qiagen #74104), treated with DNAse I (Invitrogen, # 18068015) and purified with RNeasy MinElute Cleanup Kit (Qiagen, #74204). Final concentrations and purity grades of the samples were determined using a BioDrop μLITE (Isogen Life Science) and a Bioanalyzer 2100 (Agilent Technologies Inc.).
Deep sequencing procedures
To characterize the complete transcriptomes of the studied samples, mRNA libraries from in vivo and in vitro samples obtained as explained above were prepared following the Truseq RNA sample preparation protocols from Illumina Inc. at CIC bioGUNE's genome analysis platform (Derio, Spain). Three biological replicates were studied for each sample.
Read processing and comparisons of gene expression profiles
Fifty nucleotide reads from each mRNA library were obtained using HiScanSQ (Illumina Inc., CIC bioGUNE, Bilbao, Spain). Short reads were aligned against the complete genome of A. baumannii ATCC 17978 and plasmids pAB1 and pAB2 (GenBank accession codes: NC_009085.1, NC_009083.1 and NC_009084.1, respectively). The genetic profiles comparison was done at CIC bioGUNE's genome analysis platform (Derio, Spain). Raw data were deposited in the GEO database under the accession code GSE100552.
Bioinformatic analysis
Genome analyses were done using the basic local Aligment Search Tool of the NCBI (BLAST,https://blast.ncbi.nlm.nih.gov/Blast.cgi).
Construction of isogenic deletion derivatives
In the present work, we focused on the study of the A1S_0242 gene. The Δ0242 isogenic deletion mutant derivative of the ATCC 17978 strain was constructed by deleting a region of the A1S_0242 gene. The suicide vector pMo130 (Genbank: EU862243), was used as described before [68] where upstream and downstream regions flanking the A1S_0242 gene were PCR-amplified and cloned into the pMo130 vector using primers listed in Table S2. The plasmid construction obtained was used to transform ATCC 17978 cells by electroporation [61]. Recombinant colonies representing the first crossover event were selected as previously described [69]. The second crossover event leading to gene knockout was confirmed by PCR using primers listed in Table S2 as described before [68]. The A1S_3850 was found in the genome of the 17978 strain as an A1S_0242 homologue. In order to study its interference with the A1S_0242 gene as well as discard its relevance in pathogenesis, a Δ3850 isogenic deletion mutant of the ATCC 17978 strain was constructed following the protocol described above and using the primers listed in Table S2. In addition, a double isogenic mutant strain, Δ0242/Δ3850, was performed following the same protocol where the second deletion (Δ3850) was constructed over the Δ0242 mutant.
Complementation of the mutant strains
The pWH1266-Km plasmid was constructed as previously described [68]. Then, in order to complement the Δ0242 strain, the A1S_0242 gene was amplified from the genome of the ATCC 17978 strain using primers listed in Table S2 and then cloned into the EcoRV and BamHI restriction sites of the pWH1266-Km plasmid under the control of the tetracycline resistance gene promoter using the primers listed in Table S2. The resulting construction was used to transform Δ0242 mutant cells by electroporation. Transformants were selected on kanamycin-containing plates and checked by PCR using primers listed in Table S2. Moreover, ATCC 17978 and Δ0242 strains harboring the empty pWH1266-Km vector were used as experimental controls. Finally, the Δ3850 derivative strain was also complemented following the same procedure described above.
Retrotranscription and real-time RT-PCR assays
Total RNA from ATCC 17978 strain and the isogenic mutants (OD600 = 1.0) was isolated using the High Pure RNA Isolation Kit (Roche, #11828665001). RNA samples were treated with DNAse I (Invitrogen, #18068015) and purified with GeneJET RNA Cleanup and Concentration Micro Kit (Thermo Fisher Scientific, #K0841).
In order to analyze the polycistronic nature of the A1S_0242–0244 operon, the cDNA was obtained from RNA samples using the iScript cDNA Synthesis Kit (Bio-Rad, #170–8890) following the manufacturer's recommendations. The cDNA from ATCC 17978 was amplified with the GoTaq G2 Flexi DNA Polymerase (Promega, #M7808) using pairs of primers designed to anneal to the 3′-end of every gene and the 5′-end of the next one (Table S2). Genomic DNA and total RNA without reverse transcription were used as templates for positive and negative controls, respectively, and the amplicons were detected by standard 1% agarose gel electrophoresis. The gyrB gene was used as a positive control. All the assays were performed in triplicate.
Real-time reverse transcription-PCR (qRT-PCR) was carried out to determine the expression level of the genes of interest using UPL (Roche) and TaqMan (Applied Biosystems) probes and primers listed in Table S2. The LightCycler 480 RNA Master hydrolysis probes kit (Roche, #04991885001) and the LightCycler 480 RNA instrument (Roche) were used together and the following protocol was used: initial incubation of 65 °C, 3 min, followed by a denaturation step at 95 °C for 30 s, 45 cycles at 95 °C, 15 s and 60 °C, 45 s, and a final elongation step at 40 °C, 30 s. The expression level was standardized relative to the transcription level of the housekeeping gene rpoB. All the assays were performed in triplicate.
Growth curve analysis
Fitness was assessed by measuring the growth rates of the ATCC 17978 strain and the mutant derivatives strains. Briefly, 1.5 ml of LB medium were inoculated with approximately 5 × 107 CFU of each strain, previously grown until the stationary phase, and incubated at 37°C with constant shaking at 180 rpm. Assays were performed in MH medium (normal conditions) and in MH supplemented with 200 µM of 2,2′-bipyridyl (BIP, Sigma-Aldrich, #D216305) (iron deficit conditions). Growth was monitored using 24-well plates in an Epoch 2 Microplate Spectrophotometer (BioTek Instruments, Inc.) and OD600 values were recorded every 10 min. At least three independent experiments were performed for each strain. The growth rate constant (μ) was calculated on the basis of the exponential segment of the growth curve and defined as ln2/g, where g is the doubling time or mean generation time. The results were compared using Student's t test.
Quantitative biofilm assay
Biofilm formation was determined following the protocol previously described by Tomaras et al. [23] and modified by Alvarez-Fraga et al. [68]. Briefly, colonies of A. baumannii were grown on LB plates and used to inoculate LB broth. Overnight cultures were centrifuged and the pellet washed and resuspended in 5 mL of SB medium (0.5% NaCl and 1% tryptone). A 1:100 dilution of each sample was stagnant incubated at 37°C for 48 h. In order to evaluate the total cell biomass the growth was measured at OD600. Biofilm formation ability was analyzed by crystal violet staining followed by solubilisation with ethanol-acetone. In order to avoid variations due to differences in bacterial growth under different experimental conditions, the OD580/OD600 ratio was used to normalize the amount of biofilm formed to the total cell content of each sample. Eight independent replicates were performed. Student's t-test was performed to evaluate the statistical significance of observed differences.
Adhesion to A549 human alveolar epithelial cells
The ability of the isogenic A. baumannii strains (Δ0242, Δ3850 and the double mutant Δ0242/Δ3850) to adhere to A549 human epithelial cells was evaluated and compared to the wild type strain. Invasion and adhesion abilities were analyzed as previously described by Gaddy et al. [25] with some modifications [68]. Briefly, A549 human alveolar epithelial cells were grown at 37°C and 5% CO2 in DMEM medium (Sigma-Aldrich, #D5671) containing 10% of fetal bovine serum (FBS) and 1% of penicillin-streptomycin (Gibco, #15070063). Monolayers were washed with saline solution and HBSS (Hank's balanced salt solution, Gibco, #11520476 ) without glucose (mHBSS). After that, A549 cells were infected with 107 bacteria per well and incubated, 3 h for the adherence determination, in mHBSS at 37 °C. To analyze the attachment ability of bacteria, A549 cells were washed with saline solution and lysed in 500 µL of 0.5% sodium deoxycholate. Dilutions of the lysates were plated onto LB agar and incubated at 37 °C for 24 h. Colony forming units were counted to determine bacteria that had attached to or invaded A549 cells. Four independent replicates were done. Student's t-tests were performed to evaluate the statistical significance of the observed differences.
Determination of susceptibility to oxidative stress
The susceptibility to oxidative stress of the ATCC 17978 strain type and the isogenic mutant derivative strains was determined by microdilution using paraquat (Sigma-Aldrich, #856177) to achieve oxidative stress conditions in order to obtain the Minimal Inhibitory Concentration (MIC), following the CLSI criteria [70]. Briefly, strains were grown in MH plates for 24 h at 37°C. Then, 150 µL of serial dilutions of MH medium containing paraquat were performed in 96-well plates in the presence (100 µM) or absence of the metal chelator 2,2- bipyridyl (BIP). Plates were then inoculated with 7.5 µL of a 0.5 McFarland cellular suspension containing approximately 1 × 107 CFU/mL of bacteria. Bacterial growth on plates was studied after incubation al 37°C for 24 h.
Galleria mellonella virulence assay
The virulence of the wild type strain and its derivative mutant strains was evaluated using a G. mellonella survival assay and a determination of the lethal doses (LD50 and LD100). Caterpillars were obtained from Bio Systems Technology (Exeter, UK) and stored at 15 °C prior to use. A. baumannii cells previously grown for 24 h in LB broth were collected by centrifugation and resuspended in sterile phosphate-buffered saline (PBS). Appropriate bacterial inocula were determined spectrophotometrically at OD600 and confirmed by plate counting using LB agar plates. Thus, G. mellonella survival assays were performed by injecting 10 µL-suspension containing approximately 2 × 104 CFU/larva in groups of 10 larvae as previously described [71]. Two control groups were included; not injected larvae (intact) and larvae injected with an equivalent volume of sterile PBS. The tested groups included larvae infected with ATCC 17978, Δ0242, Δ3850 and Δ0242/Δ3850 strains. After injection, the larvae were incubated at 37°C in darkness, and death was assessed at 8 h intervals over 6 days. Caterpillars were considered dead and removed if they displayed no response to probing. The resulting survival curves were plotted using the Kaplan-Meier method [72] and analyzed using the log-rank (Mantel-Cox) test.
LD50 and LD100 were calculated using groups of 7 larvae of G. mellonella infected as described above. Larvae were infected with each strain with an inoculum of 10 μL starting at 8 × 105 CFUs/larvae, and then the inocula serially diluted at 2 × 105, 8 × 104, 2.6 × 104, 8 × 103 and 2.6 × 103 CFUs/larvae. Control groups were also included. Lethal doses were obtained for 24 and 144 h post-infection [73].
Murine pneumonia virulence assay
The pneumonia model was used to evaluate the virulence ability of the ATCC 17978 and the isogenic mutant Δ0242 strain using BALB/c male mice. The procedure followed was the above described for bacterial RNA extraction from the infection, with the exception of the euthanasia that occurred using an overdose of thiopental sodium 144 h after inoculation. Death was assessed at 8 h intervals. The survival curves were plotted using the Kaplan-Meier method [72] and analyzed using the log-rank (Mantel-Cox) test.
To ascertain the relevance of the feoA gene in virulence in mice pneumonia a second series of assays was performed to determine the effect of the inactivation of feoA on the bacterial load in lungs and presence of bacteria in blood. Groups of 12 mice were intratracheally inoculated as previously described with the ATCC 17978 and the mutant Δ0242 strains. Mice were inoculated with approximately 2 x LD100 of the ATCC 17978 (12 × 107 CFUs/mouse) and observed for mortality over 72 h. All the animals were analyzed immediately after death. Blood and lung samples were obtained and processed as previously described previously [74]. Student's t-test was performed to evaluate the statistical significance of differences.
Supplementary Material
Funding Statement
Consellería de Cultura, Educación y Ordenación Universitaria Xunta de Galicia-Spain, Miguel Servet program-ISCIII-Spain, Sara Borrell Program-ISCIIII-Spain, REIPI-Spain, SEIMC-Spain, ISCIIII-Spain.
Disclosure of potential conflicts of interest
No potential conflicts of interest were disclosed.
Acknowledgements
This work has been funded by Projects PI15/00860 to GB, CP13/00226 to AB, PI11/01034 to MP and P14/00059 and PI17/01482 to MP and AB, all integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII – General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe”. The study was also funded by the project IN607A 2016/22 (Consellería de Cultura, Educación e Ordenación Universitaria) to G.B. Also supported by Planes Nacionales de I+D+i 2008–2011 / 2013–2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 and REIPI RD16/0016/006) co-financed by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth 2014–2020. J. A. Vallejo was financially supported by the Sara Borrell Programme (ISCIII, Spain CD13/00373), J.C. Vázquez-Ucha was financially supported by the Miguel Servet Programme (ISCIII, Spain CP13/00226) and M. Martínez-Guitián was financially supported by the grant Clara Roy (Spanish Society of Clinical Microbiology and Infectious Diseases). We thank M. I. Voskuil (Dept. of Immunology and Microbiology, University of Colorado Medical School, CO, USA) for providing pMo130.
References
- [1].Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. Geneva (Switzerland): World Health Organization; 2017. [Google Scholar]
- [2].Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–82. doi: 10.1128/CMR.00058-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46:1254–63. doi: 10.1086/529198. [DOI] [PubMed] [Google Scholar]
- [4].Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09). J Antimicrob Chemother. 2011;66:2070–4. doi: 10.1093/jac/dkr239. [DOI] [PubMed] [Google Scholar]
- [5].Karaiskos I, Souli M, Galani I, et al.. Colistin: still a lifesaver for the 21st century? Expert Opin Drug Metab Toxicol. 2017;13:59–71. doi: 10.1080/17425255.2017.1230200. [DOI] [PubMed] [Google Scholar]
- [6].Pournaras S, Koumaki V, Gennimata V, et al.. In Vitro Activity of Tigecycline Against Acinetobacter baumannii: Global Epidemiology and Resistance Mechanisms. Adv Exp Med Biol. 2016;897:1–14. [DOI] [PubMed] [Google Scholar]
- [7].Bou G, Cerveró G, Domínguez MA, et al.. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect. 2000;6:635–43. doi: 10.1046/j.1469-0691.2000.00181.x. [DOI] [PubMed] [Google Scholar]
- [8].Higgins PG, Dammhayn C, Hackel M, et al.. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65:233–8. doi: 10.1093/jac/dkp428. [DOI] [PubMed] [Google Scholar]
- [9].Valencia R, Arroyo LA, Conde M, et al.. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol. 2009;30:257–63. doi: 10.1086/595977. [DOI] [PubMed] [Google Scholar]
- [10].Corbella X, Montero A, Pujol M, et al.. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000;38:4086–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013;37:130–55. doi: 10.1111/j.1574-6976.2012.00344.x. [DOI] [PubMed] [Google Scholar]
- [12].Smani Y, Dominguez-Herrera J, Pachón J. Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. J Infect Dis. 2013;208:1561–70. doi: 10.1093/infdis/jit386. [DOI] [PubMed] [Google Scholar]
- [13].Lee JC, Koerten H, van den Broek P, et al.. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol. 2006;157:360–6. doi: 10.1016/j.resmic.2005.09.011. [DOI] [PubMed] [Google Scholar]
- [14].Pérez A, Merino M, Rumbo-Feal S, et al.. The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain. Virulence. 2017;8(6):959–974. doi: 10.1080/21505594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Méndez JA, Mateos J, Beceiro A, et al.. Quantitative proteomic analysis of host–pathogen interactions: a study of Acinetobacter baumannii responses to host airways. BMC Genomics. 2015;16:422. doi: 10.1186/s12864-015-1608-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Merino M, Alvarez-Fraga L, Gomez MJ, et al.. Complete Genome Sequence of the Multiresistant Acinetobacter baumannii Strain AbH12O-A2, Isolated during a Large Outbreak in Spain. Genome Announc. 2014;2: doi: 10.1128/genomeA.01182-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Acosta J, Merino M, Viedma E, et al.. Multidrug-resistant Acinetobacter baumannii Harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis. 2011;17:1064–7. doi: 10.3201/eid/1706.091866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Gaddy JA, Arivett BA, McConnell MJ, et al.. Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun. 2012;80:1015–24. doi: 10.1128/IAI.06279-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Mendez JA, Soares NC, Mateos J, et al.. Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii. J Proteome Res. 2012;11:5678–94. doi: 10.1021/pr300496c. [DOI] [PubMed] [Google Scholar]
- [20].Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol. 2008;190:1036–44. doi: 10.1128/JB.01416-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Choi AH, Slamti L, Avci FY, et al.. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1–6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009;191:5953–63. doi: 10.1128/JB.00647-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Tomaras AP, Flagler MJ, Dorsey CW, et al.. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology. 2008;154:3398–409. doi: 10.1099/mic.0.2008/019471-0. [DOI] [PubMed] [Google Scholar]
- [23].Tomaras AP, Dorsey CW, Edelmann RE, et al.. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149:3473–84. doi: 10.1099/mic.0.26541-0. [DOI] [PubMed] [Google Scholar]
- [24].de Breij A, Gaddy J, van der Meer J, et al.. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol. 2009;160:213–8. doi: 10.1016/j.resmic.2009.01.002. [DOI] [PubMed] [Google Scholar]
- [25].Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun. 2009;77:3150–60. doi: 10.1128/IAI.00096-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Dashper SG, Butler CA, Lissel JP, et al.. A novel Porphyromonas gingivalis FeoB plays a role in manganese accumulation. J Biol Chem. 2005;280:28095–102. doi: 10.1074/jbc.M503896200. [DOI] [PubMed] [Google Scholar]
- [27].Nairz M, Schroll A, Sonnweber T, et al.. The struggle for iron – a metal at the host-pathogen interface. Cell Microbiol. 2010;12:1691–702. doi: 10.1111/j.1462-5822.2010.01529.x. [DOI] [PubMed] [Google Scholar]
- [28].Chu BC, Garcia-Herrero A, Johanson TH, et al.. Siderophore uptake in bacteria and the battle for iron with the host; a bird's eye view. Biometals. 2010;23:601–11. doi: 10.1007/s10534-010-9361-x. [DOI] [PubMed] [Google Scholar]
- [29].Proschak A, Lubuta P, Grun P, et al.. Structure and biosynthesis of fimsbactins A-F, siderophores from Acinetobacter baumannii and Acinetobacter baylyi. Chembiochem. 2013;14:633–8. doi: 10.1002/cbic.201200764. [DOI] [PubMed] [Google Scholar]
- [30].Penwell WF, DeGrace N, Tentarelli S, et al.. Discovery and Characterization of New Hydroxamate Siderophores, Baumannoferrin A and B, produced by Acinetobacter baumannii. Chembiochem. 2015;16:1896–1904. doi: 10.1002/cbic.201500147. [DOI] [PubMed] [Google Scholar]
- [31].Shapiro JA, Wencewicz TA. Acinetobactin Isomerization Enables Adaptive Iron Acquisition in Acinetobacter baumannii through pH-Triggered Siderophore Swapping. ACS Infect Dis. 2016;2:157–68. doi: 10.1021/acsinfecdis.5b00145. [DOI] [PubMed] [Google Scholar]
- [32].Weaver EA, Wyckoff EE, Mey AR, et al.. FeoA and FeoC are essential components of the Vibrio cholerae ferrous iron uptake system, and FeoC interacts with FeoB. J Bacteriol. 2013;195:4826–35. doi: 10.1128/JB.00738-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Naikare H, Palyada K, Panciera R, et al.. Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun. 2006;74:5433–44. doi: 10.1128/IAI.00052-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Mortensen BL, Skaar EP. The contribution of nutrient metal acquisition and metabolism to Acinetobacter baumannii survival within the host. Front Cell Infect Microbiol. 2013;3:95. doi: 10.3389/fcimb.2013.00095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [35].Runyen-Janecky LJ, Reeves SA, Gonzales EG, et al.. Contribution of the Shigella flexneri Sit, Iuc, and Feo iron acquisition systems to iron acquisition in vitro and in cultured cells. Infect Immun. 2003;71:1919–28. doi: 10.1128/IAI.71.4.1919-1928.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36].Robey M, Cianciotto NP. Legionella pneumophila feoAB promotes ferrous iron uptake and intracellular infection. Infect Immun. 2002;70:5659–69. doi: 10.1128/IAI.70.10.5659-5669.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].Velayudhan J, Hughes NJ, McColm AA, et al.. Iron acquisition and virulence in Helicobacter pylori: a major role for FeoB, a high-affinity ferrous iron transporter. Mol Microbiol. 2000;37:274–86. doi: 10.1046/j.1365-2958.2000.01987.x. [DOI] [PubMed] [Google Scholar]
- [38].Stojiljkovic I, Cobeljic M, Hantke K. Escherichia coli K-12 ferrous iron uptake mutants are impaired in their ability to colonize the mouse intestine. FEMS Microbiol Lett. 1993;108:111–5. doi: 10.1111/j.1574-6968.1993.tb06082.x. [DOI] [PubMed] [Google Scholar]
- [39].Boyer E, Bergevin I, Malo D, et al.. Acquisition of Mn(II) in addition to Fe(II) is required for full virulence of Salmonella enterica serovar Typhimurium. Infect Immun. 2002;70:6032–42. doi: 10.1128/IAI.70.11.6032-6042.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [40].Kammler M, Schön C, Hantke K. Characterization of the ferrous iron uptake system of Escherichia coli. J Bacteriol. 1993;175:6212–9. doi: 10.1128/jb.175.19.6212-6219.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41].Stevenson B, Wyckoff EE, Payne SM. Vibrio cholerae FeoA, FeoB, and FeoC Interact To Form a Complex. J Bacteriol. 2016;198:1160–70. doi: 10.1128/JB.00930-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42].Hantke K. Regulation of ferric iron transport in Escherichia coli K12: isolation of a constitutive mutant. Mol Gen Genet. 1981;182:288–92. doi: 10.1007/BF00269672. [DOI] [PubMed] [Google Scholar]
- [43].Hantke K. Ferrous Iron Transport, p 178–184 In: Crosa J, Mey A, Payne S, Iron Transport in Bacteria. Washington, DC: ASM Press; 2004. doi: 10.1128/9781555816544.ch12. [DOI] [Google Scholar]
- [44].Hantke K. Selection procedure for deregulated iron transport mutants (fur) in Escherichia coli K 12: fur not only affects iron metabolism. Mol Gen Genet. 1987;210:135–9. doi: 10.1007/BF00337769. [DOI] [PubMed] [Google Scholar]
- [45].Cartron ML, Maddocks S, Gillingham P, et al.. Feo-transport of ferrous iron into bacteria. Biometals. 2006;19:143–57. doi: 10.1007/s10534-006-0003-2. [DOI] [PubMed] [Google Scholar]
- [46].Subashchandrabose S, Smith S, DeOrnellas V, et al.. Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection. mSphere. 2015;1: doi: 10.1128/mSphere.00013-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [47].Antunes LC, Imperi F, Towner KJ, et al.. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol. 2011;162:279–84. doi: 10.1016/j.resmic.2010.10.010. [DOI] [PubMed] [Google Scholar]
- [48].Beceiro A, Tomas M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev. 2013;26:185–230. doi: 10.1128/CMR.00059-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [49].Dorsey CW, Beglin MS, Actis LA. Detection and analysis of iron uptake components expressed by Acinetobacter baumannii clinical isolates. J Clin Microbiol. 2003;41:4188–93. doi: 10.1128/JCM.41.9.4188-4193.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [50].Catel-Ferreira M, Marti S, Guillon L, et al.. The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding. FEBS Lett. 2016;590:224–31. doi: 10.1002/1873-3468.12050. [DOI] [PubMed] [Google Scholar]
- [51].Catel-Ferreira M, Nehme R, Molle V, et al.. Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56:3826–32. doi: 10.1128/AAC.06022-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [52].Murray GL, Tsyganov K, Kostoulias XP, et al.. Global gene expression profile of Acinetobacter baumannii during bacteremia. J Infect Dis. 2017;215:S52–7. doi: 10.1093/infdis/jiw529. [DOI] [PubMed] [Google Scholar]
- [53].Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev. 2007;71:413–51. doi: 10.1128/MMBR.00012-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [54].Zimbler DL, Penwell WF, Gaddy JA, et al.. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals. 2009;22:23–32. doi: 10.1007/s10534-008-9202-3. [DOI] [PubMed] [Google Scholar]
- [55].Harding RA, Royt PW. Acquisition of iron from citrate by Pseudomonas aeruginosa. J Gen Microbiol. 1990;136:1859–67. doi: 10.1099/00221287-136-9-1859. [DOI] [PubMed] [Google Scholar]
- [56].Ratledge C, Dover LG. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881–941. doi: 10.1146/annurev.micro.54.1.881. [DOI] [PubMed] [Google Scholar]
- [57].Marshall B, Stintzi A, Gilmour C, et al.. Citrate-mediated iron uptake in Pseudomonas aeruginosa: involvement of the citrate-inducible FecA receptor and the FeoB ferrous iron transporter. Microbiology. 2009;155:305–15. doi: 10.1099/mic.0.023531-0. [DOI] [PubMed] [Google Scholar]
- [58].Ganne G, Brillet K, Basta B, et al.. Iron Release from the Siderophore Pyoverdine in Pseudomonas aeruginosa Involves Three New Actors: FpvC, FpvG, and FpvH. ACS Chem Biol. 2017;12:1056–65. doi: 10.1021/acschembio.6b01077. [DOI] [PubMed] [Google Scholar]
- [59].Louvel H, Saint Girons I, Picardeau M. Isolation and characterization of FecA- and FeoB-mediated iron acquisition systems of the spirochete Leptospira biflexa by random insertional mutagenesis. J Bacteriol. 2005;187:3249–54. doi: 10.1128/JB.187.9.3249-3254.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [60].Sahl JW, Gillece JD, Schupp JM, et al.. Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter. PLoS One. 2013;8:e54287. doi: 10.1371/journal.pone.0054287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [61].Rumbo-Feal S, Gomez MJ, Gayoso C, et al.. Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells. PLoS One. 2013;8:e72968. doi: 10.1371/journal.pone.0072968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [62].Eijkelkamp BA, Hassan KA, Paulsen IT, et al.. Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC genomics. 2011;12:126. doi: 10.1186/1471-2164-12-126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [63].Miller AF. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett. 2012;586:585–95. doi: 10.1016/j.febslet.2011.10.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [64].Lenski RE. Quantifying fitness and gene stability in microorganisms. Biotechnology. 1991;15:173–92. [DOI] [PubMed] [Google Scholar]
- [65].Madigan MT MJ, Dunlap PV, Clark DP. Brock biology of microorganisms. 12th ed. Texas, USA: Pearson Education Inc; 2009. [Google Scholar]
- [66].Hassett DJ, Cohen MS. Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J. 1989;3:2574–82. [DOI] [PubMed] [Google Scholar]
- [67].Rumbo-Feal S, Perez A, Ramelot TA, et al.. Contribution of the A. baumannii A1S_0114 Gene to the Interaction with Eukaryotic Cells and Virulence. Front Cell Infect Microbiol. 2017;7:108. doi: 10.3389/fcimb.2017.00108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [68].Álvarez-Fraga L, Pérez A, Rumbo-Feal S, et al.. Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells. Virulence. 2016;7:443–55. doi: 10.1080/21505594.2016.1145335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [69].Hamad MA, Zajdowicz SL, Holmes RK, et al.. An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei. Gene. 2009;430:123–31. doi: 10.1016/j.gene.2008.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [70].CLSI W, PA, USA Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically–Tenth Edition: Approved Standard M07-A10, 2015. [Google Scholar]
- [71].Hornsey M, Longshaw C, Phee L, et al.. In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens. Antimicrob Agents Chemother. 2012;56:3080–5. doi: 10.1128/AAC.05870-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [72].Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. J Am Statist Assoc. 1958;53:457–81. doi: 10.1080/01621459.1958.10501452. [DOI] [Google Scholar]
- [73].Lopez-Rojas R, Dominguez-Herrera J, McConnell MJ, et al.. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis. 2011;203:545–8. doi: 10.1093/infdis/jiq086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [74].Rodriguez-Hernandez MJ, Pachon J, Pichardo C, et al.. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother. 2000;45:493–501. doi: 10.1093/jac/45.4.493. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.